{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HIV infection", "anti-HIV agents", "medicinal plants", "microbicides", "natural products"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33729064", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "10"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1080/14786419.2021.1892097"], "Journal": {"ISSN": "1478-6427", "JournalIssue": {"Volume": "36", "Issue": "6", "PubDate": {"Year": "2022", "Month": "Mar"}}, "Title": "Natural product research", "ISOAbbreviation": "Nat Prod Res"}, "ArticleTitle": "<i>Anandenanthera colubrina</i> (Vell.) Brenan as an inhibitor of HIV-1 BaL infection.", "Pagination": {"StartPage": "1621", "EndPage": "1625", "MedlinePgn": "1621-1625"}, "Abstract": {"AbstractText": ["We reported the <i>in\u00a0vitro</i> anti-HIV-1 activity, cytotoxicity, cytokines expression and chemical profile of <i>Anadenanthera colubrina</i>. Cytotoxicity was evaluated on TZM-bl, HL2/3 cells and macrophages. Anti-HIV-1 activity was determined by Luciferase assay (TZM-bl cells) and by HIV-p24 quantification (macrophages) assessed by ELISA. TZM-bl and HL2/3 cells were used to determine cell-cell fusion inhibition. Cytokines expression was assessed by ELISA. Chemical composition was determined by Gas Chromatography Coupled to Mass Spectrometry. At 66.6\u2009\u00b5g/mL, the extract maintained the cell viability above 90%. At 33.28\u2009\u00b5g/mL, the extract reduced 82.8% of HIV-1 infection (TZM-bl cells) and HIV-p24 expression (macrophages). The extract inhibited approximately 70% of TZM-bl and HL2/3 cells fusion. Extract did't induce inflammatory response. Phytochemical analysis showed presence of flavonoid, phenolic acids, fatty acids and sugars. This is the first <i>s</i>tudy presenting the anti-HIV effect of <i>A. colubrina</i>, showing low cytotoxicity and no inflammatory stimuli, important requirements for a microbicide development."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Dental Medicine School of Dental Medicine, Department of Foundational Sciences, East Carolina University, Greenville, NC, USA."}, {"Identifier": [], "Affiliation": "Postgraduate Program in Dentistry, State University of Paraiba, Campina Grande, Paraiba, Brazil."}], "LastName": "Maia", "ForeName": "Carolina Medeiros de Almeida", "Initials": "CMA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Dental Medicine School of Dental Medicine, Department of Foundational Sciences, East Carolina University, Greenville, NC, USA."}], "LastName": "Pasetto", "ForeName": "Silvana", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraiba, Jo\u00e3o Pessoa, Paraiba, Brazil."}], "LastName": "Silva", "ForeName": "Joanda Paola Raimundo E", "Initials": "JPRE"}, {"Identifier": ["0000-0003-0293-2605"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraiba, Jo\u00e3o Pessoa, Paraiba, Brazil."}], "LastName": "Tavares", "ForeName": "Josean Fechine", "Initials": "JF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Postgraduate Program in Dentistry, State University of Paraiba, Campina Grande, Paraiba, Brazil."}], "LastName": "Costa", "ForeName": "Edja Maria Melo de Brito", "Initials": "EMMB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Dental Medicine School of Dental Medicine, Department of Foundational Sciences, East Carolina University, Greenville, NC, USA."}], "LastName": "Murata", "ForeName": "Ramiro Mendon\u00e7a", "Initials": "RM"}], "GrantList": [{"GrantID": "P30 AI050410", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Nat Prod Res", "NlmUniqueID": "101167924", "ISSNLinking": "1478-6419"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Colubrina"}, {"QualifierName": [], "DescriptorName": "Gas Chromatography-Mass Spectrometry"}, {"QualifierName": [], "DescriptorName": "HIV Infections"}, {"QualifierName": [], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}], "CoiStatement": "Disclosure statement. The authors declare that there are no conflict interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ara\u00fajo DRC, Silva LCN, Harand W, Fernandes JM, Soares TC, Langassner SMZ, Giordani RB, Ximenes RM, Gomes-Silva A, Silva MV, et al. 2017. Effects of rainfall on the antimicrobial activity and secondary metabolites contents of leaves and fruits of Anadenanthera colubrina from caatinga area. Pharmacog J 9:435\u2013440."}, {"Citation": "Ara\u00fajo DRC, Silva TD, Harand W, Lima CSA, Ferreira Neto JP, Ramos BA, Rocha TA, Alves HS, Sousa RS, Oliveira AP, et al. Bioguided Purification of Active Compounds from Leaves of Anadenanthera colubrina var. cebil (Griseb.) 2019. Altschul. Biomolecules 9:590.", "ArticleIdList": ["PMC6843843", "31597408"]}, {"Citation": "Besednova NN, Zvyagintseva TN, Kuznetsova TA, Makarenkova ID, Smolina TP, Fedyanina LN, Kryzhanovsky SP, Zaporozhets TS. Marine algae metabolites as promising therapeutics for the prevention and treatment of HIV/AIDS. 2019. Metabolites 9.", "ArticleIdList": ["PMC6572556", "31052506"]}, {"Citation": "Cardoso Junior O, Lima NM, Silva MGA, Aguiar VB, Carli GP, Scherrer E, Castro SBR, Alves CCS, Oliveira MAL, Carli AP. In vitro and in vivo evaluation of anti-inflammatory activity and free radical scavenging potential of leaves extract from Anadenanthera colubrina. 2020. Nat Prod Res 1\u20135.", "ArticleIdList": ["32064928"]}, {"Citation": "Carvalho DDC, Alves E, Camargos RB, Oliveira DF, Scolforo JRS, Carvalho DA, Batista TRS. Plant extracts to control Alternaria alternata in Murcott tangor fruits. 2011. Rev Iberoame Micol 28:173\u2013178.", "ArticleIdList": ["21635961"]}, {"Citation": "Farr Zuend C, Nomellini JF, Smit L, Horwitz MS. A Caulobacter crescentus microbicide protects from vaginal infection with HIV-1JR-CSF in Humanized Bone Marrow-Liver-Thymus Mice. 2019. J Virol 93.", "ArticleIdList": ["PMC6714793", "31243127"]}, {"Citation": "Guarneire GJ, Cardoso Junior O, Lima NM, Santos EA, Schulz CA, Silva WP, Batista JPO, Carli GP, Castro SBR, Alves CCSA, et al. Effect of Anadenanthera colubrina protease inhibitors a Paulinos an inflammatory mediator. 2019. Nat Prod Res 1\u20136.", "ArticleIdList": ["31198054"]}, {"Citation": "Li S, Hattori T, Kodama EN. Epigallocatechin gallate inhibits the HIV reverse transcription step. 2011. Antivir Chem Chemoter 21:239\u2013243.", "ArticleIdList": ["21730371"]}, {"Citation": "Lima RF, Alves EP, Rosalen PL, Ruiz ALTG, Duarte MCT, G\u00f3es VFF, Medeiros ACD, Pereira JV, Godoy GP, Costa EMMB. Antimicrobial and antiproliferative potential of Anadenanthera colubrina (Vell.) Brenan. 2014. Evid Based Complement Alternat Med 2014.", "ArticleIdList": ["PMC4100262", "25093029"]}, {"Citation": "Mota GS, Sartori CJ, Miranda I, Quilh\u00f3 T, Mori FA, Pereira H. Bark anatomy, chemical composition and ethanol-water extract composition of Anadenanthera peregrina and Anadenanthera colubrina. 2017. PLoS One 12.", "ArticleIdList": ["PMC5744935", "29281656"]}, {"Citation": "Newman DJ, Cragg GM. Natural products as sources of new drugs from 191 to 2014. 2016. J Nat Prod 79:629\u2013661.", "ArticleIdList": ["26852623"]}, {"Citation": "Nutan MM, Goel T, Das T, Malik S, Suri S, Rawat AKS, Srivastava SK, Tuli R, Malhora S, Gupta SK. Ellagic acid & gallic acid from Lagerstroemia speciosa L. inhibit HIV-1 infection through inhibition of HIV-1 protease & reverse transcriptase activity. 2013. Indian J Med Res 137:540\u2013548.", "ArticleIdList": ["PMC3705663", "23640562"]}, {"Citation": "Panthong P, Bunluepuech K, Boonnak N, Chaniad P, Pianwanit S, Wattanapiromsakul C, Tewtrakul S. Anti-HIV-1 integrase activity and molecular docking of compounds from Albizia procera bark. 2015. Pharm Biol 53:1861\u20131866.", "ArticleIdList": ["25868621"]}, {"Citation": "Pasetto S, Pardi V, Murata RM. Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model. 2014. Plos One 9.", "ArticleIdList": ["PMC4278898", "25546350"]}, {"Citation": "Rocha EALSS, Medeiros ACD, Castro RD, Saraiva KL, Godoy GP, Silva LRA, Aleixo CSS, Silva PG, Costa EMMB. Antifungal Activity, Phytochemical Characterization and Thermal Profile of Anadenanthera colubrina (Vell.) Brenan. 2017. Pesqui Bras Odontopediatria Clin Integr 17:e3389."}, {"Citation": "Silva LCN, Miranda RCM, Gomes EB, Ara\u00fajo JM, Silva MV, Miranda RCM, Macedo AJ, Figueiredo RCBQ, Correia MTS. Evaluation of combinatory effects of Anadenanthera colubrina, Libidibia ferrea and Pityrocarpa moniliformis fruits extracts and erythromycin against Staphylococcus aureus. 2013. J Med Plant Res 7:2358\u20132364."}, {"Citation": "Silva DR, Rosalen PL, Freires IA, Sardi JCO, Lima RF, Lazarini JG, Costa TKVL, Pereira JV, Godoy GP, Costa EMMB. Anadenanthera Colubrina vell Brenan: anti-Candida and antibiofilm activities, toxicity and therapeutical action. 2019. Braz Oral Res 33:1\u201311.", "ArticleIdList": ["30970088"]}, {"Citation": "Sivro A, Su RC, Plummer FA, Ball TB. Interferon response in HIV infection: from protection to disease. 2014. AIDS Rev 1:43\u201351.", "ArticleIdList": ["24522779"]}, {"Citation": "Stone A 2010. Regulatory Issues in Microbicide Development World Health Organization: Geneva, Switzerland."}, {"Citation": "Suedee A, Tewtrakul S, Panichayupakarant P. Anti-HIV-1 integrase activity of Mimusops elengi leaf extracts. 2014. Pharm Biol. 52:58\u201361.", "ArticleIdList": ["24033292"]}, {"Citation": "UNAIDS. 2018. Fact sheet\u2014latest global and regional statistics on the status of the AIDS epidemic Geneva, Switzerland."}, {"Citation": "Wu H, Ma G, Yang Q, Zhu Y, Huang L, Tian Y, Yang X, Zhang M, Chen CH, Morris-Natschke SL, et al. Discovery and synthesis of novel beesioside I derivatives with potent anti-HIV activity. 2019. Eur J Med Chem 166:159\u2013166.", "ArticleIdList": ["PMC6464118", "30703659"]}, {"Citation": "Yadav IK, Jaiswal D, Singh HP, Mishra A, Jain DA. Anti-HIV drugs from natural sources. 2009. Pharm Res 1:93\u2013109."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "17", "Hour": "12", "Minute": "22"}, {"Year": "2023", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33729064", "NIHMS1758760", "PMC9078876", "10.1080/14786419.2021.1892097"]}}], "PubmedBookArticle": []}